NCT06848309 Dissecting Human Immune Responses to Infection With Influenza or SARS-CoV-2 Status RECRUITING Phase N/A
NCT06841913 Woodsmoke Exposure, Influenza Infection, and Nasal Immunity Status RECRUITING Phase PHASE4
NCT06821061 A Study to Learn About How the Flu and COVID-19 Vaccines Act in Healthy People Status COMPLETED Phase PHASE1/PHASE2
NCT06817096 Efficacy and Safety of Nitazoxanide 600 Mg in the Outpatient Treatment of COVID-19 and Influenza Status NOT_YET_RECRUITING Phase PHASE3
NCT06815250 Enhancing Maternal Vaccine Knowledge and Uptake: The InTroDuce-Programme Trial Status RECRUITING Phase NA
NCT06780566 Routine Application of Point-of-care PCR Test to Identify and Direct Therapy for Acute Respiratory Infection in the Emergency Department Trial Status NOT_YET_RECRUITING Phase NA
NCT06779981 A Prospective Epidemiological Study Evaluating Occurrences of Influenza-like Illness Status COMPLETED Phase N/A
NCT06774859 Study to Assess the Safety, Pharmacokinetics, and Efficacy of Baloxavir Marboxil in Chinese Pediatric Participants 1 to <12 Years of Age With Influenza Symptoms Status COMPLETED Phase PHASE3
NCT06762587 Oseltamivir and Baloxavir Marboxil for Prophylaxis Against Influenza Under a Hospital-based Setting Status NOT_YET_RECRUITING Phase NA
NCT06744205 A Study on the Safety and Immunogenicity of Hexavalent Influenza mRNA Vaccine in Adult Participants 50 Years of Age and Older Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT06694389 Study to Investigate the Immunogenicity, Reactogenicity, and Safety of mRNA-1083 Vaccine (SARS-CoV-2 [COVID-19] and Influenza) in Adults ≥50 Years of Age Status COMPLETED Phase PHASE3
NCT06692400 The Effects of Endotracheal Suctioning on Pain and Serum Markers Status RECRUITING Phase NA
NCT06667063 Clinical Study on the Immune Response Characteristics of Novel Coronavirus and Influenza Virus Infection Status RECRUITING Phase N/A
NCT06643156 Study to Assess the Tolerability, Safety and Efficacy of GP681 Powder for Oral Suspension Status COMPLETED Phase PHASE1
NCT06641180 Study to Evaluate Immunogenicity and Safety of a High-Dose Influenza Vaccine in Adults 50 Through 64 Years of Age Status COMPLETED Phase PHASE3